Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple mechanisms
- Molecular classification
- Other (represents a class describing drugs that act via more than one mechanism)
01
Overview
"Multiple mechanisms" denotes the phenomenon where a drug or therapy acts through more than one molecular or biological pathway. This term applies to polypharmacology, multi-target drugs, or combination therapies, which intentionally modulate several targets to address complex diseases or drug resistance. It is not a molecular entity or specific receptor, but a descriptive property used in drug classification and systems pharmacology. Current terminology favors specifying the predominant molecular targets or mechanisms to increase clarity and therapeutic precision. This approach is central in treating multifactorial diseases and is supported by advances in systems biology, computational modeling, and precision biomarker strategies.
02
Mechanism of action
Drugs classified as "multiple mechanisms" may act by: - Agonizing/antagonizing multiple receptors - Inhibiting several enzymes - Modulating multiple ion channels and transporters - Impacting several nodes in signaling or metabolic pathways
03
Biological functions
Other (general property of drugs or therapeutic interventions, not a single biological function)
04
Disease associations
Other (multiple mechanisms can contribute to efficacy in diverse diseases such as cancer, complex infections, and multifactorial disorders)
05
Safety considerations
Increased risk for off-target effects and toxicityComplexity of predicting efficacy and side effectsNeed for precision biomarker and patient selection strategiesDrug resistance may be reduced, but rare unpredictable adverse events may occur
06
Interacting drugs
Nonsteroidal anti-inflammatory drugs (NSAIDs)
4 more in the full profile.
07
Biomarkers
Expression of HER2 in breast cancerEGFR in certain cancersAlpha-synuclein for Parkinson’s diseaseNeurofilament light chain for neurodegenerative disease
Beyond the preview
Go deeper on Multiple mechanisms.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multiple mechanisms.